What should be done if a woman discovers she is pregnant while taking doxycycline?

Discontinue Doxycycline Immediately Upon Pregnancy Discovery

If a woman discovers she is pregnant while taking doxycycline, she should stop the medication immediately and consult her healthcare provider to discuss alternative treatments if ongoing therapy is needed. 1

FDA Classification and Primary Concerns

Doxycycline is FDA Pregnancy Category D, meaning there is positive evidence of human fetal risk 1. The primary concerns are:

• Permanent tooth discoloration (yellow-gray-brown) when used during tooth development, which begins in the last half of pregnancy 1
• Enamel hypoplasia has been documented 1
• Skeletal development effects - tetracyclines cross the placenta, are found in fetal tissues, and can cause retardation of skeletal development 1
• Bone formation interference - all tetracyclines form stable calcium complexes in bone-forming tissue 1

Risk Assessment by Trimester

First Trimester Exposure

The evidence regarding first trimester exposure shows conflicting data:

• An expert TERIS review concluded therapeutic doses are "unlikely to pose substantial teratogenic risk," though data quality was limited 1
• A large case-control study (18,515 cases vs 32,804 controls) showed a weak but marginally significant association with total malformations (0.3% vs 0.19%, p=0.01) 1, 2
• Critically, when confined to the organogenesis period (months 2-3), no association was seen except a marginal relationship with neural tube defects based on only 2 cases 1
• A 2025 large population-based cohort of 265,686 pregnancies found no increased risk of major congenital malformations with first trimester exposure (7.7% vs 7.0%, adjusted RR 1.07,95% CI 0.93-1.23) 3
• A prospective study of 81 pregnancies with 43 women treated for 10 days in early first trimester reported all infants were normal at 1 year 1

Third Trimester Exposure

• Absolutely contraindicated - causes permanent tooth discoloration and enamel hypoplasia 1
• Associated with very low birthweight in recent data 3
• Affects developing fetal bones and teeth 1

Clinical Action Algorithm

1. Immediate cessation of doxycycline upon pregnancy confirmation
2. Document timing of exposure (gestational age at start and stop)
3. Assess indication for doxycycline:
   • If treating active infection requiring ongoing therapy, switch to pregnancy-safe alternative immediately
   • If prophylactic use (e.g., acne, malaria prophylaxis), discontinue without replacement
4. Counsel the patient:
   • First trimester exposure: Reassure based on most recent high-quality evidence showing no increased malformation risk 3
   • Any trimester: Explain tooth/bone development risks if continued
5. Arrange appropriate prenatal care with detailed anatomic ultrasound at 18-20 weeks
6. Document exposure in prenatal records for pediatric follow-up regarding dental development

Important Caveats

The one exception to immediate discontinuation: Life-threatening infections where no safer alternative exists (e.g., anthrax exposure, Rocky Mountain spotted fever) - in these rare scenarios, the mortality risk outweighs fetal risks 4. However, treatment should be switched to safer alternatives as soon as susceptibility testing allows 4.

Common pitfall: Some sources cite older data suggesting teratogenic risk, but the most recent and largest study (2025, n=265,686) found no association with major malformations 3. However, this does NOT justify continuing doxycycline during pregnancy when alternatives exist, given the well-established risks to tooth and bone development in later pregnancy 1.

Breastfeeding consideration: While tetracyclines are excreted in breast milk, short-term use is not necessarily contraindicated, though prolonged exposure effects are unknown 1. A risk-benefit discussion is required.